Accessibility Menu
ChromoCure logo

ChromoCure(OTC) KKUR

Market Cap$15.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-99%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
ChromoCure last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-18
ChromoCure stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-10
1 month+0%USD 0.002026-07-02
3 month+0%USD 0.002026-05-19
Year to date+0%USD 0.002025-12-23
1 year+0%USD 0.002025-07-08
3 year+0%USD 0.002023-08-03
5 year-99%USD 0.002021-08-18
Since inception-100%USD 120.002005-04-27

ChromoCure Financials at a Glance

Market Cap

$15.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

20.48 (High)

Price

$0.00

Volume

999,999

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

KKUR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ChromoCure

ChromoCure, Inc. is a pioneering company specializing in innovative systems for cancer identification. The organization focuses on developing non-toxic and non-invasive strategies for cancer treatment and research, aiming to revolutionize the healthcare landscape.

Products and Services
  • Chromosomal Scanner Series 200 for cancer detection
  • Research on non-toxic cancer treatment methods
  • Innovative solutions for genomic characteristic identification
Growth Outlook
  • Established in 2001, with a strong foundation in cancer research
  • Focus on non-invasive treatment strategies aligns with market trends
  • Potential for expansion in the growing medical specialties sector
Financial Highlights
  • Market capitalization of $8,200 indicates growth potential
  • Recent trading volume averages over 1.4 million shares
  • Stock price range between $0.000001 and $0.0001 shows stability
ChromoCure, Inc. is positioned in the healthcare sector, specifically within medical specialties, and has a unique offering that addresses a critical need in cancer detection. The company's flagship product, the Chromosomal Scanner Series 200, is designed to identify a genomic characteristic present in all cancers, providing a significant advantage in early detection. With a commitment to non-toxic treatment methods, ChromoCure is aligned with the increasing demand for safer healthcare solutions. The company's market capitalization and trading volume suggest a growing interest among investors, reflecting confidence in its innovative approach and potential for future growth.
AI Generated • Aug 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Reno, US

KKUR Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$15.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

15.00B

Volume

1000.00K

Avg. Volume

232.55K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

ChromoCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$15.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDITMedite Cancer Diagnostics, Inc.
$0.00+0.00%
CEVECeres Ventures, Inc.
$0.00+0.00%
GSRXGSRX Industries Inc.
$0.00+0.00%
BTAXBiostax Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.84+0.06%
IBITiShares Bitcoin Trust
$41.21+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.75-0.05%
SPCXSpace Exploration Technologies
$131.31-0.06%

Questions About KKUR

What is the current price of ChromoCure?

ChromoCure is trading at $0.00 per share.

What is the 52-week range for ChromoCure?

Over the past 52 weeks, ChromoCure has traded between $0.00 and $0.00.

How much debt does ChromoCure have?

ChromoCure total debt is unavailable.

How much cash does ChromoCure have on hand?

ChromoCure does not have cash on hand data available.

What is ChromoCure’s dividend yield?

ChromoCure does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services